A simple comorbidity scale predicts clinical outcomes and costs in dialysis patients

American Journal of Medicine

Volumn 108, Issue 8, 2000, Pages 609-613

  Beddhu, Srinivasan ^a   Bruns, Frank J ^a   Saul, Melissa ^a   Seddon, Patricia ^a   Zeidel, Mark L ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; COMORBIDITY; DATA BASE; FEMALE; HEALTH CARE COST; HEMODIALYSIS PATIENT; HOSPITAL ADMISSION; HUMAN; INFORMATION RETRIEVAL; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; OUTCOMES RESEARCH; PERITONEAL DIALYSIS; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE PAYMENT; RATING SCALE; UNIVERSITY HOSPITAL;

ADOLESCENT; ADULT; AGE FACTORS; AGED; CHILD; CHILD, PRESCHOOL; COMORBIDITY; DIABETES MELLITUS; FEMALE; HEALTH CARE COSTS; HEALTH STATUS INDICATORS; HOSPITALIZATION; HUMANS; INFANT; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PENNSYLVANIA; PERITONEAL DIALYSIS; PREDICTIVE VALUE OF TESTS; RENAL DIALYSIS; RISK; TREATMENT OUTCOME; UNITED STATES;

EID: 0034213185     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(00)00371-5     Document Type: Article

References (23)

1. 1. 1997 Annual Data Report. Bethesda, Md: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; April 1997:21-34;tables Al,B3.
2. 2. Hull AR. The legislative and regulatory process in the end-stage renal disease program, 1973 through 1997. Semin Nephrol. 1997;17: 160-169.
3. 3. Cooper BS, Eggers PW, Edington BM. Development of an end-stage renal disease managed care demonstration. Advance Renal Replace Ther. 1997;4:332-339.
4. 4. Keane WF, Collins AJ. Influence of comorbidity on mortality and morbidity in patients treated with hemodialysis. Am J Kidney Dis. 1994;24:1010-1018.
5. 5. Shapiro FL, Umen A. Risk factors in hemodialysis patient survival. ASAIO J. 1983;6:176-184.
6. 6. Plough AL, Schwartz M, Salem SR, et al. Severity analysis in ESRD: a risk group approach. ASAIO J. 1985;8:33-40.
7. 7. Pollack VE, Pesce A, Kant KS. Continuous quality improvement in chronic disease: a computerized medical record enables description of severity index to evaluate outcomes in ESRD. Am J Kidney Dis. 1992;19:514-522.
8. 8. Bruns FJ, Seddon P, Saul M, Zeidel ML. The cost of caring for end-stage kidney disease patients: an analysis based on hospital financial transaction records. J Am Soc Nephrol. 1998;9:884-890.
9. 9. Charlson ME, Pompei P, Ales AL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis. 1987;40:373-383.
10. 10. Held PJ, Port FK, Gaylin DS, et al. Comorbid conditions and correlations with mortality risk among 3,399 incident hemodialysis patients. Am J Kidney Dis. 1992;5(suppl 2):32-38.
11. 11. Habach G, Bloembergen WE, Mauger EA, et al. Hospitalization among United States dialysis patients: hemodialysis versus peritoneal dialysis. J Am Soc Nephrol. 1995;5:1940-1948.
12. 12. United States Renal Data System 1992 Annual Report. Bethesda, Md: National Institutes of Health; publication no 92-3176, October 1992.
13. 13. United States Renal Data System 1997 Annual Report. Bethesda, Md: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; April 1997:143-161.
14. 14. Steinman TI. Managed care, capitation and the future of nephrology. J Am Soc Nephrol. 1997;8:1618-1623.
15. 15. Bodenheimer T. The Oregon Health Plan. Lessons for the nation. NEJM. 1 997;37:720-723.
16. 16. Hutchinson T, Michaud L, Thomas DC. Comparing survival of patients on dialysis and after renal transplantation. ASAIO J. 1 982; 8:18-21.
17. 17. Greenfield S, Sullivan L, Silliman RA, et al. Principles and practice of case mix adjustment: applications to end-stage renal disease. Am J Kidney Dis. 1994;24:298-307.
18. 18. Kurtin P, Nissenson AR. Variation in end-stage renal disease patient outcomes: what we know, what should we know, and how to find it out? J Am Soc Nephrol. 1993;3:1738-1747.
19. 19. Nicolucci A, Cubasso D, Labbrozzi D, et al. Effect of coexistent diseases on survival of patients undergoing dialysis. ASAIO J. 1992; 38:M291-295.
20. 20. McClellan WM, Anson C, Birkelli K, Tuttle E. Functional status and quality of life: predictors of early mortality among patients entering treatment for end-stage renal disease. J Clin Epidemiol. 1991;44:83-89.
21. 21. Owen WF Jr, Lew NL, Liu Y, et al. The urea reduction ratio and serum albumin concentration as predictors of mortality in patients undergoing hemodialysis. NEJM. 1993;329:1001-1006.
22. 22. Foley RN, Parfery PS, Harnett JD, et al. Impact of hypertension on cardiomyopathy, morbidity and mortality in end-stage renal disease. Kidney Int. 1996;49:1379-1385.
23. 23. National Kidney Foundation. NKF-DOQI clinical practice guidelines for hemodialysis adequacy. Am J Kidney Dis. 1997;30(suppl 2):515-566.